Mr. Miguel Martin reports

AURORA RECEIVES SUPPORT FROM LEADING INDEPENDENT PROXY ADVISER INSTITUTIONAL SHAREHOLDER SERVICES INC. FOR THE 2026 ANNUAL GENERAL MEETING OF SHAREHOLDERS

Institutional Shareholder Services Inc. (ISS) has recommended that Aurora's shareholders vote for all resolutions set forth in the company's management information circular in advance of its upcoming annual general meeting of shareholders.

• ISS has recommended that Aurora's shareholders vote for all director nominees and meeting resolutions;
• Shareholders are encouraged to vote early in favour of all resolutions -- every vote matters, no matter how many shares you own;
• Shareholders who have questions or need assistance with voting their shares should contact Aurora's strategic adviser and proxy solicitation agent, Kingsdale Advisors, by telephone at 1-800-749-9052 or by e-mail at contactus@kingsdaleadvisors.com or visit www.MyAuroraVote.com.

The circular is available on the company's website and under Aurora's profile on SEDAR+.

Welcoming the positive ISS recommendations, Miguel Martin, Aurora's executive chairman and chief executive officer, stated: "We are pleased that ISS has recognized the strong governance framework and board oversight in place at Aurora by recommending that shareholders vote for all meeting resolutions put forward at our upcoming AGM. We appreciate the trust and support of our shareholders as we continue to expand our global medical cannabis business and focus on building long-term value."

Shareholder meeting details

The meeting will be held virtually on Friday, Aug. 7, 2026, at 1 p.m. Eastern Time/11 a.m. Mountain Time and will be conducted via live webcast. The virtual meeting format allows shareholders and duly appointed proxyholders to have an equal opportunity to participate regardless of geographic location or ownership. Meeting details, including instructions on how to vote, can be found within the circular.

At the meeting, shareholders will be asked to consider and vote on the following items, each of which the board of directors unanimously recommends a vote for:

• Fix the number of directors to be elected at five;
• Elect directors for the ensuing year;
• Appoint the auditor for the ensuing year;
• A non-binding advisory resolution on the company's approach to executive compensation (say-on-pay).

Before voting, the company also invites shareholders to view a message from Miguel Martin, chief executive officer, and Simona King, chief financial officer, as they reflect on fiscal 2026 and the future for Aurora.

Shareholders are encouraged to review the circular and vote early to ensure their shares are represented. Voting now means one less thing to think about as the proxy voting deadline draws near. The deadline for voting your shares is at 1 p.m. Eastern Time on Wednesday Aug. 5, 2026.

Aurora's board of directors recommends that shareholders vote for all the director nominees and meeting resolutions.

Your vote is important. Vote your shares for Aurora's director nominees and meeting resolutions as soon as possible

Shareholder questions and voting assistance

Shareholders who have any questions or require assistance with voting may contact Aurora's proxy solicitation agent and shareholder communications adviser:

Kingsdale Advisors

Call:  1-800-749-9052 (toll-free in North America)

Text or call:  416-623-4172 (outside North America)

About Aurora Cannabis Inc.

Aurora is a global leader in medical cannabis, dedicated to improving lives through scientific expertise, proven performance and a deep commitment to patient care. Aurora serves medical markets across Canada, Europe, Australia and New Zealand with a portfolio of trusted, leading brands including Aurora, MedReleaf, Pedanios, IndiMed, San Raf and Whistler Medical Marijuana Corp. With world-class good-manufacturing-practice-certified manufacturing facilities in Canada and Germany, and a team of industry-leading professionals, Aurora continues to expand its global footprint and deliver consistent, high-quality cannabis products with the purpose of Opening the World to Cannabis.

We seek Safe Harbor.